ETFsXtrackers MSCI China A UCITS ETF 1C
Xtrackers

Xtrackers MSCI China A UCITS ETF 1C

XX2D LSEAccumulatingLuxembourg
Last close · EUR
32.12EUR
-0.25% · -€0.08
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
XX2DBase
Fund charges
Not publishedFee basis unverified
Fund size
Not published
Return 1Y
-3.7%
Sharpe 3Y
0.35
Volatility 1Y
15.2%annualised
Holdings
415Fund holdings

Performance

Compare
  • XX2D-3.7%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
XX2D-6.7%-9.4%-11.0%-3.6%-3.7%+30.9%-1.7%
MSCI World-2.8%-0.6%+7.8%+14.3%+14.1%+65.6%+64.8%
Gap to MSCI World-3.9%-8.7%-18.8%-17.9%-17.8%-34.7%-66.5%

Risk and return

Sharpe ratio · 3Y
0.35
Below MSCI World · 1.24
Return p.a.
+8.5%
Volatility
22.4%
Max loss
-25.7%Apr 2025

Sharpe vs indices

MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
CAC 40
0.37
XX2D
0.35
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
18.3%
Holdings
415
As of
Fund holdings
  1. 1KWEICHOW MOUTAI ACNE0000018R84.15%
  2. 2CONTEMPORARY AMPEREX TECHNOLOGY ACNE1000036622.56%
  3. 3CHINA MERCHANTS BANK ACNE000001B332.01%
  4. 4CHINA YANGTZE POWER LTD ACNE000001G871.66%
  5. 5AGRICULTURAL BANK OF CHINA ACNE100000RJ01.43%
  6. 6ZIJIN MINING GROUP LTD ACNE100000B241.38%
  7. 7ZHONGJI INNOLIGHT ACNE100001CY91.36%
  8. 8PING AN INSURANCE (GROUP) OF CHINACNE000001R841.32%
  9. 9CAMBRICON TECHNOLOGIES CORPORATIONCNE1000041R81.22%
  10. 10INDUSTRIAL AND COMMERCIAL BANK OFCNE000001P371.21%

Countries

Classified 100.0%
Largest
100.0%China
Top 3
100.0%
Effective number
1.01 / HHI

Market cap

Weight vs holdings

18.3%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.